January 8, 2016
PTC Therapeutics and Massachusetts General Hospital Collaborate on Rare Disease Research
Read More
October 26, 2015
PTC Announces Results from Phase 3 ACT DMD Clinical Trial of TranslarnaTM (ataluren) in Patients with Duchenne Muscular Dystrophy
Read More
July 12, 2015
Mark Chapman Shares an Investor’s Guide for The Race To Cure Duchenne Muscular Dystrophy
Read More
X